September 08, 2026 09:18 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Eiffel Tower staff strike after female workers 'sidelined' during Hindu group visit | ‘When will character assassination of women stop?’ Kangana Ranaut amid Udhayanidhi-Trisha row | 11 arms instead of 10! Suvendu Adhikari apologises over Durga image in Bengal govt ad amid Bageshwar Baba row | ‘Meat is core to Shakta Hinduism’: PM Modi adviser hits back at Bageshwar Baba over non-veg ban appeal | ‘No one can dictate what Bengalis eat’: BJP’s blunt message amid Bageshwar Baba’s Durga Puja food row | Delhi hostel collapse: Owner detained after seven die in Satya Niketan tragedy | No Muslims, Aadhaar card and tilak mandatory: VHP lays down rules for Garba, Dandiya in Maharashtra | 'No non-veg near Durga Puja pandals': Bageshwar Baba's big Bengal appeal sparks controversy | 'Law will take its action': Vijay's zero tolerance on insulting women weeks after Udhayanidhi's arrest | Delhi Metro's big warning to content creators: Don't try this viral stunt or face action

GlaxoSmithKline records 11% growth for Q2

| | Nov 06, 2014, at 04:31 am
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
 
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
 
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.